ESR1 and breast cancer: Mahanine induces apoptosis via mitochondrial pathways, increases ROS, activates caspases 3, 7, and 9, upregulates Bax, downregulates Bcl-2, and targets estrogen receptor alpha and CDKs in leukemia and breast cancer cells (70).